Education/CredentialsFellowship: Walter Reed Army Medical Center (Hematology, Oncology, Bone Marrow Transplantation)Residency: Walter Reed Army Medical Center (Internal Medicine)Doctor of Medicine: University of ArkansasBachelor of Arts: Hendrix College (Chemistry) Board Certifications & LicensesAmerican Board of Internal Medicine (Hematology) (Certification Date: 2007-11-14) SpecialtiesHematologyInternal MedicineMedical Oncology Contact Information Medical Sciences Building Office 513-558-4231 Email byrd2jc@ucmail.uc.edu Clinical Interests Hematology and OncologyLeukemiaAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome Peer Reviewed Publications Larkin, Karilyn T M; Byrd, John C 2021. Whole-genome sequencing for myeloid disease: one assay to stratify them all? Nature reviews. Clinical oncology, , Korman, Abraham M; Hastings, Justin G; Byrd, John C; Kaffenberger, Benjamin H 2017. Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia. JAMA dermatology, 153 1, 108-110Flinn, Ian W; Ruppert, Amy S; Harwin, William; Waterhouse, David; Papish, Steven; Jones, Jeffrey A; Hainsworth, John; Byrd, John C 2016. A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia. American journal of hematology, 91 10, 1020-5Sanchez-Aguilera, A; Rattmann, I; Drew, D Z; Müller, L U W; Summey, V; Lucas, D M; Byrd, J C; Croce, C M; Gu, Y; Cancelas, J A; Johnston, P; Moritz, T; Williams, D A 2010. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia, 24 1, 97-104Treon, Steven P.; Agus, David B.; Link, Brian; Rodrigues, Gilberto; Molina, Arturo; Lacy, Martha Q.; Fisher, David C.; Emmanouilides, Christos; Richards, Arthur I.; Clark, Bruce; Lucas, Marjorie S.; Schlossman, Robert; Schenkein, David; Lin, Boris; Kimby, Eva; Anderson, K. C.; Byrd, John C. 2001. CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia. Journal of immunotherapy : official journal of the Society for Biological Therapy, 24 3, 272-279
Clinical Interests Hematology and OncologyLeukemiaAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
Peer Reviewed Publications Larkin, Karilyn T M; Byrd, John C 2021. Whole-genome sequencing for myeloid disease: one assay to stratify them all? Nature reviews. Clinical oncology, , Korman, Abraham M; Hastings, Justin G; Byrd, John C; Kaffenberger, Benjamin H 2017. Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia. JAMA dermatology, 153 1, 108-110Flinn, Ian W; Ruppert, Amy S; Harwin, William; Waterhouse, David; Papish, Steven; Jones, Jeffrey A; Hainsworth, John; Byrd, John C 2016. A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia. American journal of hematology, 91 10, 1020-5Sanchez-Aguilera, A; Rattmann, I; Drew, D Z; Müller, L U W; Summey, V; Lucas, D M; Byrd, J C; Croce, C M; Gu, Y; Cancelas, J A; Johnston, P; Moritz, T; Williams, D A 2010. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia, 24 1, 97-104Treon, Steven P.; Agus, David B.; Link, Brian; Rodrigues, Gilberto; Molina, Arturo; Lacy, Martha Q.; Fisher, David C.; Emmanouilides, Christos; Richards, Arthur I.; Clark, Bruce; Lucas, Marjorie S.; Schlossman, Robert; Schenkein, David; Lin, Boris; Kimby, Eva; Anderson, K. C.; Byrd, John C. 2001. CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia. Journal of immunotherapy : official journal of the Society for Biological Therapy, 24 3, 272-279
Larkin, Karilyn T M; Byrd, John C 2021. Whole-genome sequencing for myeloid disease: one assay to stratify them all? Nature reviews. Clinical oncology, , Korman, Abraham M; Hastings, Justin G; Byrd, John C; Kaffenberger, Benjamin H 2017. Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia. JAMA dermatology, 153 1, 108-110Flinn, Ian W; Ruppert, Amy S; Harwin, William; Waterhouse, David; Papish, Steven; Jones, Jeffrey A; Hainsworth, John; Byrd, John C 2016. A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia. American journal of hematology, 91 10, 1020-5Sanchez-Aguilera, A; Rattmann, I; Drew, D Z; Müller, L U W; Summey, V; Lucas, D M; Byrd, J C; Croce, C M; Gu, Y; Cancelas, J A; Johnston, P; Moritz, T; Williams, D A 2010. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia, 24 1, 97-104Treon, Steven P.; Agus, David B.; Link, Brian; Rodrigues, Gilberto; Molina, Arturo; Lacy, Martha Q.; Fisher, David C.; Emmanouilides, Christos; Richards, Arthur I.; Clark, Bruce; Lucas, Marjorie S.; Schlossman, Robert; Schenkein, David; Lin, Boris; Kimby, Eva; Anderson, K. C.; Byrd, John C. 2001. CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia. Journal of immunotherapy : official journal of the Society for Biological Therapy, 24 3, 272-279